Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03347149 · ClinicalTrials.gov registry record

Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (USA)

A clinical trial, sponsored by Philips Healthcare.

Completed
Registry status
1,336
Enrollment target

NCT03347149: Completed study, sponsored by Philips Healthcare.

NCT03347149 is a clinical trial that has completed, run by Philips Healthcare. The registered enrollment target is 1,336 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03347149 has completed, sponsored by Philips Healthcare.

COMPLETED
Registry status
1,336 participants
Enrollment target

Study Summary

This Clinical Study will be conducted as a comparative study focusing on usability and efficiency by comparing alarm burden pre- and post- implementation of an "Alarm Advisor software".

Primary Outcome

red and yellow alarms with subgroups

Interventions

  • DEVICE Alarm Advisor Software

Trial Details

FieldValue
Enrollment Target 1,336 participants
Start Date 2017-08-28
Est. Completion 2018-03-11
Philips Healthcare

10 total trials

What the finished NCT03347149 record still lists

NCT03347149 is an observational study that tracks outcomes without assigning an intervention. Its 1,336 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Alarm Advisor Software is the first listed.

NCT03347149 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03347149 about?

NCT03347149 is a clinical study titled "Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (USA)". This Clinical Study will be conducted as a comparative study focusing on usability and efficiency by comparing alarm burden pre- and post- implementation of an "Alarm Advisor software".

What is the current status of trial NCT03347149?

This trial is currently completed. The enrollment target is 1,336 participants. The study started on 2017-08-28. Estimated completion is 2018-03-11.

What interventions are being tested in trial NCT03347149?

The interventions under investigation include: Alarm Advisor Software (DEVICE).

Who is sponsoring clinical trial NCT03347149?

This trial is sponsored by Philips Healthcare, which has 10 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06972056 · 1,335 participants · Phase 4

    Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • NCT05415761 · 1,332 participants · NA

    Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care

  • NCT05511298 · 1,332 participants

    Empowering Students Project

  • NCT06934876 · 1,332 participants

    Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03347149, the US trial registry maintained by the National Library of Medicine. NCT03347149 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.